Novo Nordisk A/S – Page 2

How Ozempic Turned a 1974 Hit Into an Inescapable Jingle

The diabetes drug has become a phenomenon, and “Oh, oh, oh, Ozempic!” — a takeoff of the Pilot song “Magic” — has played a big part in its story.

By Craig Marks

Artificial Intelligence Computer Chips Huang, Jen-Hsun internal-storyline-no Novo Nordisk A/S NVIDIA Corporation OpenAI Labs

Investors Shrug off Nvidia’s ‘A.I. Woodstock’

The chipmaker unveiled a new high-speed processor at its developer conference to power an “industrial revolution,” but its sky-high valuation is coming under scrutiny.

By Andrew Ross Sorkin Ravi Mattu Bernhard Warner Sarah Kessler

Diabetes Drugs (Pharmaceuticals) Drugstores Eli Lilly and Company Factories and Manufacturing Health Insurance and Managed Care IQVIA Inc Novo Nordisk A/S Obesity Prices (Fares, Fees and Rates) Semaglutide (Drug) Shortages Weight

6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions

An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.

By Reed Abelson and Rebecca Robbins

Drugs (Pharmaceuticals) Health Insurance and Managed Care Insurance North Carolina Novo Nordisk A/S Obesity

Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs

Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.

By Rebecca Robbins

mosaec